高级搜索
乳腺可视化触诊成像系统对乳腺癌的诊断价值[J]. 肿瘤防治研究, 2012, 39(06): 645-648. DOI: 10.3971/j.issn.1000-8578.2012.06.008
引用本文: 乳腺可视化触诊成像系统对乳腺癌的诊断价值[J]. 肿瘤防治研究, 2012, 39(06): 645-648. DOI: 10.3971/j.issn.1000-8578.2012.06.008
Diagnostic Value of Sure-touch Tactile Breast Imaging for Breast Cancer[J]. Cancer Research on Prevention and Treatment, 2012, 39(06): 645-648. DOI: 10.3971/j.issn.1000-8578.2012.06.008
Citation: Diagnostic Value of Sure-touch Tactile Breast Imaging for Breast Cancer[J]. Cancer Research on Prevention and Treatment, 2012, 39(06): 645-648. DOI: 10.3971/j.issn.1000-8578.2012.06.008

乳腺可视化触诊成像系统对乳腺癌的诊断价值

Diagnostic Value of Sure-touch Tactile Breast Imaging for Breast Cancer

  • 摘要: 目的 探讨乳腺可视化触诊成像系统(Sure-Touch)诊断乳腺癌的价值。方法对在湘雅医院乳腺科初诊的111例乳腺肿物患者,分别独立行Sure-Touch、B型超声、钼靶X线检查,后全部病例经病理确诊恶性64例,良性47例。比较三种检查方法的差异。结果Sure-Touch对乳腺肿块诊断的敏感度、特异性、准确率分别为87.5%、83.0%、85.6%,其诊断的准确率与B型超声(81.1%)比较,差异无统计学意义。三种检查方法对乳腺癌患者的检查结果比较,差异无统计学意义。Sure-Touch联合B型超声或Sure-Touch联合钼靶对乳腺癌诊断的敏感度显著高于单一方法。结论Sure-Touch联合B型超声或Sure-Touch联合钼靶的联合诊断,可进一步提高乳腺癌的影像诊断符合率。

     

    Abstract: Objective To assess the value of Sure-Touch tactile breast imaging in the diagnosis of breast cancer. Methods One hundred and eleven patients with breast mass were examined separately by the Sure -Touch,ultrasound as well as mammography,and subsequently diagnosed by pathological examination as 64 malignant cases and 47 benign cases.The differences of the three examinations were compared. Results The sensitivity,specificity and accuracy of Sure-Touch were 87.5%,83.0%,and 85.6%,respectively.The accuracy of Sure-Touch for breast mass was not different significantly compared with ultrasound(81.1%).For patients with breast cancer,the results of three examinations were not statistically different from each other.The sensitivity for breast cancer by combined application of Sure-Touch and ultrasound or Sure-Touch and mammography was higher than that by single one. Conclusion Combined application of Sure-Touch and ultrasound or Sure-Touch and mammography ,could further improve the imaging diagnostic consistent rate for breast cancer.

     

/

返回文章
返回